On Tuesday, Tango Therapeutics Inc (NASDAQ: TNGX) was 6.87% up from the session before settling in for the closing price of $1.31. A 52-week range for TNGX has been $1.03 – $12.02.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 103.26%. When this article was written, the company’s average yearly earnings per share was at -14.29%. With a float of $59.12 million, this company’s outstanding shares have now reached $108.11 million.
Let’s determine the extent of company efficiency that accounts for 155 employees. In terms of profitability, gross margin is 83.79%, operating margin of -355.86%, and the pretax margin is -322.17%.
Tango Therapeutics Inc (TNGX) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Tango Therapeutics Inc stocks. The insider ownership of Tango Therapeutics Inc is 45.31%, while institutional ownership is 55.46%. The most recent insider transaction that took place on Feb 04 ’25, was worth 8,289. In this transaction General Counsel of this company sold 2,774 shares at a rate of $2.99, taking the stock ownership to the 68,570 shares. Before that another transaction happened on Feb 05 ’25, when Company’s General Counsel sold 2,556 for $3.16, making the entire transaction worth $8,081. This insider now owns 66,014 shares in total.
Tango Therapeutics Inc (TNGX) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -14.29% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -5.61% during the next five years compared to 7.47% growth over the previous five years of trading.
Tango Therapeutics Inc (NASDAQ: TNGX) Trading Performance Indicators
You can see what Tango Therapeutics Inc (TNGX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 6.26. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.70.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.21, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -1.32 in one year’s time.
Technical Analysis of Tango Therapeutics Inc (TNGX)
Looking closely at Tango Therapeutics Inc (NASDAQ: TNGX), its last 5-days average volume was 0.66 million, which is a drop from its year-to-date volume of 0.74 million. As of the previous 9 days, the stock’s Stochastic %D was 47.80%. Additionally, its Average True Range was 0.16.
During the past 100 days, Tango Therapeutics Inc’s (TNGX) raw stochastic average was set at 14.12%, which indicates a significant decrease from 69.81% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 110.63% in the past 14 days, which was higher than the 90.91% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5236, while its 200-day Moving Average is $4.6307. However, in the short run, Tango Therapeutics Inc’s stock first resistance to watch stands at $1.4700. Second resistance stands at $1.5400. The third major resistance level sits at $1.6350. If the price goes on to break the first support level at $1.3050, it is likely to go to the next support level at $1.2100. Should the price break the second support level, the third support level stands at $1.1400.
Tango Therapeutics Inc (NASDAQ: TNGX) Key Stats
There are 108,108K outstanding shares of the company, which has a market capitalization of 151.75 million. As of now, sales total 42,070 K while income totals -130,300 K. Its latest quarter income was 4,120 K while its last quarter net income were -37,670 K.
